In this episode of the Investment Climate Podcast, host Alex Shandrovsky interviews Jennifer Côté, CEO and Co-Founder of Opalia, a biotechnology company based in Montreal. Opalia is pioneering animal-free dairy by producing real whole milk from bovine mammary cells. Côté shares insights on navigating a challenging funding climate in 2026, including closing a $3.2M CAD Seed round and leveraging non-dilutive government grants.

Opalia's goal is to eliminate the global reliance on cattle by manufacturing authentic whole milk using a capital-efficient, mammalian cell-based bioreactor system. The company has raised $6M CAD total over 6 years and recently closed the first $3.2M CAD tranche of their Seed round. Opalia stands out in the cellular agriculture industry for its innovative approach and remarkable capital efficiency, setting a benchmark for sustainable dairy production in the future.